Yumanity
is a Massachusetts-based biopharmaceutical company that develops and commercializes drugs for the treatment of neurodegenerative diseases... Read moreYumanity
is a Massachusetts-based biopharmaceutical company that develops and commercializes drugs for the treatment of neurodegenerative diseases... Read more
News
Apr 17, 2023
MarketScreener
Yumanity: Yumanity Therapeutics : Regulation FD Presentation - Form 8-K
Dec 19, 2022
The Business Journals: Seattle
Yumanity: Kineta finalizes reverse merger with Yumanity, secures additional funding
Dec 05, 2022
Citybizlist
Yumanity: Yumanity Therapeutics Proposed Asset Sale to Janssen and Merger with Kineta
Nov 14, 2022
FinanzNachrichten
Yumanity: Yumanity Therapeutics Inc: Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
Nov 10, 2022
MarketScreener
Yumanity: Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
Aug 04, 2022
Associated Press News
Yumanity: Yumanity: Q2 Earnings Snapshot
Jul 05, 2022
Acrofan
Yumanity: YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YM
Jun 17, 2022
MarketScreener
Yumanity: Yumanity Therapeutics : Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit - Form 8-K
Jun 08, 2022
Medthority
Yumanity: Yumanity Therapeutics acquires Kineta, Inc., and with it KVA12.1 , a potential best-in-class VISTA blocking immunotherapy
Jun 08, 2022
centralcharts
Press Release: Yumanity : YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
Yumanity Competitors
1
2
3
4
5
6
7
8
9